The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

被引:2053
作者
Choe, H
Farzan, M
Sun, Y
Sullivan, N
Rollins, B
Ponath, PD
Wu, LJ
Mackay, CR
LaRosa, G
Newman, W
Gerard, N
Gerard, C
Sodroski, J
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115
[2] LEUKOSITE INC,CAMBRIDGE,MA 02142
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,BOSTON,MA 02115
[4] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,PERLMUTTER LAB,DEPT PEDIAT,DEPT MED,CHILDRENS HOSP,BOSTON,MA 02115
关键词
D O I
10.1016/S0092-8674(00)81313-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the ability of chemokine receptors and related G protein-coupled receptors to facilitate infection by primary, clinical HIV-1 isolates. CCR5, when expressed along with CD4, the HIV-1 receptor, allowed cell lines resistant to most primary HIV-1 isolates to be infected. CCR3 facilitated infection by a more restricted subset of primary viruses, and binding of the CCR3 ligand, eotaxin, inhibited infection by these isolates. Utilization of CCR3 and CCR5 on the target cell depended upon the sequence of the third variable (V3) region of the HIV-1 gp120 exterior envelope glycoprotein. The ability of various members of the chemokine receptor family to support the early stages of HIV-1 infection helps to explain viral tropism and beta-chemokine inhibition of primary HIV-1 isolates.
引用
收藏
页码:1135 / 1148
页数:14
相关论文
共 108 条
  • [31] Cloning, expression, and characterization of the human eosinophil eotaxin receptor
    Daugherty, BL
    Siciliano, SJ
    DeMartino, JA
    Malkowitz, L
    Sirotina, A
    Springer, MS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) : 2349 - 2354
  • [32] COMPLEMENTATION OF MURINE CELLS FOR HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE CD4-MEDIATED FUSION IN HUMAN MURINE HETEROKARYONS
    DRAGIC, T
    CHARNEAU, P
    CLAVEL, F
    ALIZON, M
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (08) : 4794 - 4802
  • [33] ACQUIRED IMMUNODEFICIENCY SYNDROME - EPIDEMIOLOGIC, CLINICAL, IMMUNOLOGICAL, AND THERAPEUTIC CONSIDERATIONS
    FAUCI, AS
    MACHER, AM
    LONGO, DL
    LANE, HC
    ROOK, AH
    MASUR, H
    GELMANN, EP
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) : 92 - 106
  • [34] MOLECULAR-CLONING OF THE CDNA AND CHROMOSOMAL LOCALIZATION OF THE GENE FOR A PUTATIVE 7-TRANSMEMBRANE SEGMENT (7-TMS) RECEPTOR ISOLATED FROM HUMAN SPLEEN
    FEDERSPPIEL, B
    MELHADO, IG
    DUNCAN, AMV
    DELANEY, A
    SCHAPPERT, K
    CLARKLEWIS, I
    JIRIK, FR
    [J]. GENOMICS, 1993, 16 (03) : 707 - 712
  • [35] HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor
    Feng, Yu
    Broder, Christopher C.
    Kennedy, Paul E.
    Berger, Edward A.
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 186 (11) : 872 - 877
  • [36] FENYO EM, 1988, J VIROL, V62, P4414
  • [37] A MOLECULAR CLONE OF HTLV-III WITH BIOLOGICAL-ACTIVITY
    FISHER, AG
    COLLALTI, E
    RATNER, L
    GALLO, RC
    WONGSTAAL, F
    [J]. NATURE, 1985, 316 (6025) : 262 - 265
  • [38] IDENTIFICATION OF THE PRINCIPAL NEUTRALIZING DETERMINANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AS A FUSION DOMAIN
    FREED, EO
    MYERS, DJ
    RISSER, R
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (01) : 190 - 194
  • [39] HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION OF EOSINOPHILS IN HUMAN BONE-MARROW CULTURES
    FREEDMAN, AR
    GIBSON, FM
    FLEMING, SC
    SPRY, CJ
    GRIFFIN, GE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) : 1661 - 1664
  • [40] FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS
    GALLO, RC
    SALAHUDDIN, SZ
    POPOVIC, M
    SHEARER, GM
    KAPLAN, M
    HAYNES, BF
    PALKER, TJ
    REDFIELD, R
    OLESKE, J
    SAFAI, B
    WHITE, G
    FOSTER, P
    MARKHAM, PD
    [J]. SCIENCE, 1984, 224 (4648) : 500 - 503